--- title: "Prime Medicine (PRME.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/PRME.US/norm.md" symbol: "PRME.US" name: "Prime Medicine" parent: "https://longbridge.com/en/quote/PRME.US.md" datetime: "2026-05-21T22:31:46.378Z" locales: - [en](https://longbridge.com/en/quote/PRME.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/PRME.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/PRME.US/norm.md) --- # Prime Medicine (PRME.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.2774 | -0.2599 | -0.3151 | -0.4071 | -0.3965 | | ROE | -198.91% | -130.40% | -181.72% | -250.76% | -159.62% | | Revenue | 856000.00 | 838000.00 | 1.23M | 1.11M | 1.45M | | Net income | -49.12M | -46.08M | -50.58M | -52.59M | -51.89M | | Operating income | -50.65M | -48.61M | -53.97M | -53.38M | -52.39M | | Gross margin | -3884.23% | -4041.89% | -3491.02% | -188.61% | -2689.68% | | Net margin | -5738.55% | -5498.69% | -4129.14% | -4716.68% | -3568.78% | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 294.73M | 342.73M | 385.01M | 279.01M | 328.16M | | Leverage | 3.84 | 2.84 | 2.38 | 4.58 | 3.07 | | BVPS | 0.4247 | 0.6827 | 0.9151 | 0.4645 | 0.8374 | | Turnover | 0.0130 | 0.0145 | 0.0167 | 0.0184 | 0.0120 | | Cash & STI | 135.50M | 177.68M | 213.29M | 101.75M | 144.26M | | Inv & Rec | - | - | - | - | - | | LT assets | 142.15M | 146.75M | 139.91M | 144.03M | 150.34M | | Net debt | -20.98M | -61.25M | -95.15M | 17.99M | -23.11M | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -42.71M | -37.26M | -35.04M | -41.41M | -48.86M | | Investing CF | 43.39M | 28.33M | -92.12M | 2.77M | -47.74M | | Financing CF | 393000.00 | 562000.00 | 144.75M | 197000.00 | 6.00M | | Free CF | -25.72M | -7.77M | -17.48M | -27.35M | -32.77M | | OCF coverage | -19957.94% | -12846.90% | -14185.83% | -2634.35% | -2017.22% | | Repaid & issued | - | - | - | - | - | | CapEx | -214000.00 | -290000.00 | -247000.00 | -1.57M | -2.42M |